TuHURA Biosciences, Inc./NV Quarterly Retained Earnings (Accumulated Deficit) in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
TuHURA Biosciences, Inc./NV quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q2 2011 to Q3 2024.
  • TuHURA Biosciences, Inc./NV Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2024 was -$162M, a 4.88% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$162M -$7.54M -4.88% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$160M -$8.5M -5.62% Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$158M -$9.51M -6.43% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$156M -$10.8M -7.44% Dec 31, 2023 10-Q 2024-02-14
Q3 2023 -$155M -$13.2M -9.34% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$151M -$15M -11% Jun 30, 2023 10-K 2024-10-07
Q1 2023 -$148M -$17.1M -13.1% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$145M -$19.2M -15.3% Dec 31, 2022 10-Q 2023-02-14
Q3 2022 -$141M -$21.7M -18.1% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 -$136M -$25.1M -22.6% Jun 30, 2022 10-K 2023-09-18
Q1 2022 -$131M -$26.4M -25.3% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 -$126M -$27.7M -28.3% Dec 31, 2021 10-Q 2022-02-11
Q3 2021 -$120M -$27.2M -29.5% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 -$111M -$41.5M -59.5% Jun 30, 2021 10-K 2022-09-27
Q1 2021 -$104M -$38.6M -58.6% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 -$97.8M -$33.9M -53% Dec 31, 2020 10-Q 2021-02-12
Q3 2020 -$92.4M -$30.2M -48.6% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 -$69.7M -$9.14M -15.1% Jun 30, 2020 10-K 2021-09-28
Q1 2020 -$65.9M -$7.91M -13.6% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 -$63.9M -$7.63M -13.6% Dec 31, 2019 10-Q 2020-02-13
Q3 2019 -$62.2M -$7.72M -14.2% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 -$60.6M -$8.14M -15.5% Jun 30, 2019 10-K 2020-09-18
Q1 2019 -$58M -$7.96M -15.9% Mar 31, 2019 10-Q 2019-05-14
Q4 2018 -$56.3M -$9.25M -19.7% Dec 31, 2018 10-Q 2019-02-11
Q3 2018 -$54.5M -$10.6M -24.3% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 -$52.4M -$11.3M -27.5% Jun 30, 2018 10-K 2019-09-09
Q1 2018 -$50M -$11.6M -30.3% Mar 31, 2018 10-Q 2018-05-15
Q4 2017 -$47M -$10.7M -29.5% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 -$43.8M -$8.99M -25.8% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 -$41.1M -$8.88M -27.5% Jun 30, 2017 8-K 2019-06-03
Q1 2017 -$38.4M -$14.4M -59.8% Mar 31, 2017 10-Q 2017-05-12
Q4 2016 -$36.3M -$13.4M -58.7% Dec 31, 2016 10-Q 2017-02-10
Q3 2016 -$34.8M -$14.6M -72.2% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 -$32.2M -$13.6M -73.2% Jun 30, 2016 10-K 2017-09-27
Q1 2016 -$24M -$5.54M -30% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 -$22.9M -$6.49M -39.6% Dec 31, 2015 10-Q 2016-02-12
Q3 2015 -$20.2M -$4.46M -28.3% Sep 30, 2015 10-Q 2015-11-16
Q2 2015 -$18.6M -$4.35M -30.5% Jun 30, 2015 10-K 2016-09-13
Q1 2015 -$18.5M Mar 31, 2015 10-Q 2016-05-12
Q4 2014 -$16.4M Dec 31, 2014 10-Q 2016-02-12
Q3 2014 -$15.8M Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$14.3M Jun 30, 2014 10-K/A 2015-11-16
Q1 2012 -$56.6M Mar 31, 2012 10-Q/A 2012-06-05
Q4 2011 -$53.5M Dec 31, 2011 10-Q 2012-02-07
Q3 2011 -$42.6K* Sep 30, 2011 10-Q 2011-11-10
Q2 2011 -$38.7K* Jun 30, 2011 10-Q/A 2012-06-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.